A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

Investigator Site #1022, Philadelphia

Investigator Site #1026, Rockville

Investigator Site #1043, Sandy Springs

Investigator Site #1035, Macon

Investigator Site #1025, Hialeah

Investigator Site #1028, Miami

Investigator Site #1030, Fort Lauderdale

Investigator Site #1039, Brandon

Investigator Site #1042, Tampa

Investigator Site #1013, Brandon

Investigator Site #1029, Birmingham

Investigator Site #1034, Louisville

Investigator Site #1017, Owensboro

Investigator Site #1011, Indianapolis

Investigator Site #1027, South Bend

Investigator Site #1038, Warren

Investigator Site # 1010, Clarkston

Investigator Site #1009, Bay City

Investigator Site #1031, New Brighton

Investigator Site #1012, Rapid City

Investigator Site # 1005, Rolling Meadows

Investigator Site #1036, Overland Park

Investigator Site #1023, Rogers

Investigator Site #1033, Oklahoma City

Investigator Site # 1015, Houston

Investigator Site #1006, San Antonio

Investigator Site #1041, South Jordan

Investigator Site # 1001, Phoenix

Investigator Site #1014, Las Vegas

Investigator Site #1024, Los Angeles

Investigator Site # 1018, Los Angeles

Investigator Site # 1007, Santa Monica

Investigator Site # 1002, Sherman Oaks

Investigator Site #1021, Encinitas

Investigator Site #1016, San Diego

Investigator Site # 1008, Fremont

Investigator Site # 1019, Portland

Investigator Site #1037, Portsmouth

Investigator Site #2001, Edmonton

Investigator Sie #2008, Surrey

Investigator Site #2003, Winnipeg

Investigator Site #2006, London

Investigator Site #2004, Mississauga

Investigator Site #2007, North Bay

Investigator Site #2005, Oakville

Investigator Site #2009, Toronto

Investigator Site #2002, Waterloo

Investigator Site #2010, Québec

Investigator Site #5515, Svitavy

Investigator Site #5507, Nový Jičín

Investigator Site #5514, Pardubice

Investigator Site #5506, Prague

Investigator Site #5505, Prague